RxDoctor Payments DataLook up a doctor →

Amish Prasad, DO

Cardiovascular Disease · Las Vegas, NVNPI 1194955021

Payments from drug & device makers

$57,729in general payments, 2019–2025

Across 648 payments — averaging $89.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$23K
  • Medtronic$8K
  • Abiomed$5K
  • Abbott$5K
  • Cvrx, Inc.$4K
  • Penumbra, Inc.$2K
  • plus $12K from 41 others
$124in research payments, 2019–2025

Across 1 payment — averaging $124.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$124

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)56$22,764
Medtronic(2 entities)108$7,722
Abiomed60$5,296
Abbott64$4,796
Cvrx, Inc.28$3,570
Penumbra, Inc.7$1,908
Roche Molecular Systems, Inc.7$1,856
Novartis52$1,083
Pfizer26$869
Actelion Pharmaceuticals US, Inc.16$707
Merck19$599
Amgen30$575
Johnson & Johnson13$573
Shockwave Medical, Inc3$560
Regeneron Healthcare Solutions, Inc.19$496
AstraZeneca10$450
Roche Diagnostics Corporation5$431
E.r. Squibb & Sons, L.L.C.14$364
Esperion Therapeutics, Inc.6$312
Boston Scientific14$305
Novo Nordisk13$267
Cardiovascular Systems Inc.2$214
Alnylam Pharmaceuticals Inc.10$212
GSK10$202
Boehringer Ingelheim8$181
Bridgebio Pharma, Inc.11$167
Grifols USA, LLC3$165
Bardy Diagnostics, Inc.1$125
Amarin Pharma, Inc.1$123
Heartflow, Inc.2$80
Bayer4$78
W. L. Gore & Associates, Inc.1$69
Sanofi-aventis U.S. LLC3$65
Baxter Healthcare1$63
Kiniksa Pharmaceuticals International, PLC2$55
Kiniksa Pharmaceuticals, Ltd.2$55
La Jolla Pharmaceutical Company3$52
Edwards Lifesciences2$51
GE HealthCare1$48
Lantheus Medical Imaging, Inc.2$37
Irhythm Technologies, Inc.2$34
Lilly USA, LLC2$34
Kestra Medical Technology Services, Inc.1$29
Sanofi1$25
Philips North America LLC1$25
Gilead1$20
Ionis Pharmaceuticals, Inc.1$16

How this compares

$57,729 in reported general payments places this provider in the 90th percentile of 165 cardiovascular disease providers in Nevada.

See all cardiovascular disease providers in Nevada →

Medicare billing

Part B allowed, 2024
$578,964
Medicare patients
1,601
Services billed
5,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →